# Early Response to MASH Drug Linked to Resolution, Fibrosis Improvement

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/aasld/123798) · 2026-11-09 · Medicine
Page: https://themorning.science/story/early-response-to-mash-drug-linked-to-resolution-fibrosis-improvement-73ddc2c72b1ee73a
Kind: research · Impact: medium

## In brief

- In patients treated with resmetirom (Rezdiffra), early responses in blood and imaging biomarkers were associated with resolution of MASH.
- The same early biomarker responses were also associated with fibrosis improvement.
- The report comes from MedPage Today's coverage of an AASLD meeting; the full study details are not in the provided excerpt.

## Why it matters

If early blood and imaging biomarker changes track with MASH resolution and fibrosis improvement, they could help clinicians and researchers assess treatment response sooner than waiting for later outcomes.

## Coverage

- [Early Response to MASH Drug Linked to Resolution, Fibrosis Improvement](https://www.medpagetoday.com/meetingcoverage/aasld/123798) — MedPageToday.com - medical news for physicians, 2026-11-09

Tags: mash, resmetirom, liver fibrosis, biomarkers, hepatology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science